There are 717 resources available
Updates in oncological emergencies
Presenter: Alexandre Chan
Session: Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice
Resources:
Slides
Webcast
Several potential new targets are missed regarding current guidelines
Presenter: Fabrice Barlesi
Session: Are large NGS panels really changing patient outcomes?
Resources:
Slides
Webcast
Are the addition of these new targets really changing patient outcomes globally?
Presenter: Jürgen Wolf
Session: Are large NGS panels really changing patient outcomes?
Resources:
Slides
Webcast
Designing a pragmatic strategy for adequately genotyping advanced NSCLC
Presenter: Myung-Ju Ahn
Session: Are large NGS panels really changing patient outcomes?
Resources:
Slides
Webcast
Immunotherapy biomarkers: What should we be prepared to assess beyond PDL1?
Presenter: Caicun Zhou
Session: Are large NGS panels really changing patient outcomes?
Resources:
Slides
Webcast
48MO - Ribociclib (RIB) + letrozole (LET) in Asian patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2−) advanced breast cancer (ABC): Subgroup analysis of the phase IIIb CompLEEment-1 trial
Presenter: Sanjoy Chatterjee
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
378MO - EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%
Presenter: Ahmet Sezer
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast
5MO - Evaluation of pathological complete response (pCR) after neoadjuvant chemo-radiation therapy for primary breast cancer (JCOG0306A1)
Presenter: Tadahiko Shien
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
4MO - Machine learning intratumoral and peritumoral magnetic resonance imaging radiomics for predicting disease-free survival in patients with early-stage breast cancer (RBC-01 Study)
Presenter: Wei Ren
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
299MO - Efficacy and safety of entrectinib in an Asian population with <italic>NTRK</italic> fusion-positive (fp) solid tumours or <italic>ROS1</italic>-fp NSCLC
Presenter: Daniel Shao Weng Tan
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast